Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12341040 | 0.81 | — | — | |
| SCHEMBL1755720 | 0.77 | SELE (0.38) | — | |
| SCHEMBL15935249 | 0.74 | MRGPRX1 (0.38) | PDPK1MRGPRX1 | |
| SCHEMBL25086385 | 0.73 | PDPK1 (0.38) | PDPK1 | |
| SCHEMBL24571467 | 0.69 | PDPK1 (0.32) | PDPK1MRGPRX1 | |
| SCHEMBL12341044 | 0.68 | ADORA2A (0.41) | — | |
| SCHEMBL13587137 | 0.67 | ADORA2A (0.33) | — | |
| SCHEMBL12024986 | 0.67 | CYP2A6 (0.50) | PDPK1MRGPRX1 | |
| SCHEMBL23478783 | 0.67 | PDPK1 (0.38) | PDPK1 | |
| SCHEMBL25054164 | 0.67 | CYP1A2 (0.38) | PDPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8158825-B2 | Modified malonate derivatives | MERCK SHARP & DOHME CORP. (US) | 2012-04-17 | — | — | US | disclosed |
| US-20100160327-A1 | Modified Malonate Derivatives | MERCK SHARP & DOHME LLC | 2010-06-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100160327-A1 | Modified Malonate Derivatives | ME2, ME3, ME1 | PDPK1 1505/4885MRGPRX1 1724/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.